Published in Invest Ophthalmol Vis Sci on December 01, 2007
Sjögren's syndrome: an old tale with a new twist. Arch Immunol Ther Exp (Warsz) (2009) 1.16
Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13. Mucosal Immunol (2010) 1.13
Modulation of conjunctival goblet cell function by inflammatory cytokines. Mediators Inflamm (2013) 0.92
Deletion of interferon-γ delays onset and severity of dacryoadenitis in CD25KO mice. Arthritis Res Ther (2012) 0.85
Age-Related Conjunctival Disease in the C57BL/6.NOD-Aec1Aec2 Mouse Model of Sjögren Syndrome Develops Independent of Lacrimal Dysfunction. Invest Ophthalmol Vis Sci (2015) 0.78
Do Genetic Alterations in Sex Steroid Receptors Contribute to Lacrimal Gland Disease in Sjögren's Syndrome? Open Endocrinol J (2009) 0.77
Age-related spontaneous lacrimal keratoconjunctivitis is accompanied by dysfunctional T regulatory cells. Mucosal Immunol (2016) 0.76
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (1986) 35.41
Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev (1979) 16.45
Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol (1983) 14.36
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (1992) 12.92
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell (1995) 6.88
T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J Exp Med (1980) 6.62
Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity (2001) 3.84
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med (1994) 3.24
An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc Natl Acad Sci U S A (1997) 2.67
Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr Biol (1998) 2.24
Roles of interferon-gamma and interleukin-4 in murine lupus. J Clin Invest (1997) 2.04
Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum (1996) 1.97
Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol (1994) 1.89
Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. J Immunol (1989) 1.78
IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J Immunol (1997) 1.68
Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology (1987) 1.17
CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma. J Immunol (2000) 1.08
Reactive lymphocytes in lacrimal gland and vasculitic renal lesions of autoimmune MRL/lpr mice express L3T4. J Exp Med (1987) 1.08
Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice. Cell Immunol (1992) 1.08
Interleukin 13 elicits a subset of the activities of its close relative interleukin 4. Stem Cells (1994) 1.02
MRL/lpr mice produce anti-Ro 52,000 MW antibodies: detection, analysis of specificity and site of production. Immunology (1994) 0.96
Anti-La antibody production by MRL-1pr/1pr mice. Analysis of fine specificity. J Immunol (1991) 0.94
Immunoregulatory properties of IL-13: its potential role in atopic disease. Int Arch Allergy Immunol (1995) 0.94
Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus. J Immunol (2000) 0.93
Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci (2004) 0.92
Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice. Invest Ophthalmol Vis Sci (2000) 0.89
Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions. Invest Ophthalmol Vis Sci (1991) 0.86
Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment. Eur J Immunol (1994) 0.85
Murine models of Sjögren's syndrome. Immunohistologic analysis of different strains. Invest Ophthalmol Vis Sci (1988) 0.85
Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice. Invest Ophthalmol Vis Sci (2004) 0.84
Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci (2001) 0.83
Presence of B7-2+ dendritic cells and expression of Th1 cytokines in the early development of sialodacryoadenitis in the IqI/Jic mouse model of primary Sjörgren's syndrome. Autoimmunity (2003) 0.83
Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells. Arthritis Rheum (1999) 0.81
Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum (2009) 1.77
Subluxation of suture-fixated posterior chamber intraocular lenses a clinicopathologic study. Ophthalmology (2007) 1.61
Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am (2009) 1.35
Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs. persistent infections. Microb Pathog (2004) 1.27
Transcriptome profiling of Saccharomyces cerevisiae during a transition from fermentative to glycerol-based respiratory growth reveals extensive metabolic and structural remodeling. Mol Genet Genomics (2006) 1.26
Dual role of COUP-TF-interacting protein 2 in epidermal homeostasis and permeability barrier formation. J Invest Dermatol (2008) 1.23
Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimers Dis (2008) 1.21
Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection. Microbes Infect (2002) 1.19
Detection of nucleotide variability in rpoB in both rifampin-sensitive and rifampin-resistant strains of Chlamydia trachomatis. Antimicrob Agents Chemother (2003) 1.17
Occult thyroid eye disease in patients presenting with dry eye symptoms. Am J Ophthalmol (2009) 1.13
Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice. Immunology (2005) 1.11
Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae. Nanomedicine (2013) 1.09
Persistent Chlamydiae and chronic arthritis. Arthritis Res (2001) 1.05
Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. FEMS Immunol Med Microbiol (2006) 1.03
Protective immunity to chlamydial genital infection: evidence from animal studies. J Infect Dis (2010) 1.03
Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae. J Rheumatol (2002) 1.02
Soluble egg antigens from Schistosoma mansoni induce angiogenesis-related processes by up-regulating vascular endothelial growth factor in human endothelial cells. J Infect Dis (2002) 1.01
Dendrimer-enabled modulation of gene expression in Chlamydia trachomatis. Mol Pharm (2012) 0.99
Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice. Immunology (2004) 0.94
Lamellar keratoplasty using gamma-irradiated corneal lenticules. Am J Ophthalmol (2010) 0.94
Molecular biology of infectious agents in chronic arthritis. Rheum Dis Clin North Am (2009) 0.93
Infectious agents and multiple sclerosis--are Chlamydia pneumoniae and human herpes virus 6 involved? J Neuroimmunol (2003) 0.93
New insights into Chlamydia and arthritis. Promise of a cure? Ann Rheum Dis (2013) 0.93
Current concepts and techniques in keratoprosthesis. Curr Opin Ophthalmol (2005) 0.92
Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci (2004) 0.92
Dendrimer-enabled transformation of Chlamydia trachomatis. Microb Pathog (2013) 0.91
The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. Microb Pathog (2005) 0.91
Rsf1p, a protein required for respiratory growth of Saccharomyces cerevisiae. Curr Genet (2003) 0.90
The evolving story of Chlamydia-induced reactive arthritis. Curr Opin Rheumatol (2010) 0.90
Immunosuppression for posterior uveitis. Retina (2005) 0.90
The molecular genetic basis of mitochondrial malfunction in bladder tissue following outlet obstruction. J Urol (2004) 0.90
Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue. Microb Pathog (2009) 0.89
The transcript profile of persistent Chlamydophila (Chlamydia) pneumoniae in vitro depends on the means by which persistence is induced. FEMS Microbiol Lett (2008) 0.89
Electron microscopic investigation of the lens capsule and conjunctival tissues in individuals with clinically unilateral pseudoexfoliation syndrome. Ophthalmology (2007) 0.87
Kinematics of intracellular chlamydiae provide evidence for contact-dependent development. J Bacteriol (2009) 0.86
Spermatogenetic expression of RNA-binding motif protein 7, a protein that interacts with splicing factors. J Androl (2003) 0.85
Chlamydophila (Chlamydia) pneumoniae infection of human astrocytes and microglia in culture displays an active, rather than a persistent, phenotype. Am J Med Sci (2006) 0.84
Keratoprosthesis in high-risk pediatric corneal transplantation: first 2 cases. Arch Ophthalmol (2006) 0.84
Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice. Invest Ophthalmol Vis Sci (2004) 0.84
Chlamydia and chronic arthritis. Ann Med (2011) 0.84
Human herpesvirus 6 and Chlamydia pneumoniae as etiologic agents in multiple sclerosis - a critical review. Microbes Infect (2002) 0.83
Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain. Int J Med Microbiol (2008) 0.83
Reactive arthritis and internal derangement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 0.83
Up-regulation of a cellular protein at the translational level by a retrovirus. Proc Natl Acad Sci U S A (2008) 0.83
Molecular mimicry and horror autotoxicus: do chlamydial infections elicit autoimmunity? Expert Rev Mol Med (2006) 0.82
Rsf1p is required for an efficient metabolic shift from fermentative to glycerol-based respiratory growth in S. cerevisiae. Yeast (2009) 0.82
Detection of DNA from a range of bacterial species in the knee joints of dogs with inflammatory knee arthritis and associated degenerative anterior cruciate ligament rupture. Microb Pathog (2007) 0.82
Etiology and pathogenesis of late-onset Alzheimer's disease. Curr Allergy Asthma Rep (2014) 0.81
Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles. Biomaterials (2011) 0.80
Chlamydia trachomatis is present and metabolically active during the remitting phase in synovial tissues from patients with chronic Chlamydia-induced reactive arthritis. Am J Med Sci (2013) 0.80
Biomimetic design in microparticulate vaccines. Biomaterials (2003) 0.80
Regulation of Sam68 activity by small heat shock protein 22. J Cell Biochem (2006) 0.80
The YJR127C/ZMS1 gene product is involved in glycerol-based respiratory growth of the yeast Saccharomyces cerevisiae. Curr Genet (2005) 0.80
Fate of Chlamydophila pneumoniae in human monocyte-derived dendritic cells: long lasting infection. Microb Pathog (2006) 0.80
No correlation between giant cell arteritis and Chlamydia pneumoniae infection: investigation of 189 patients by standard and improved PCR methods. J Clin Microbiol (2009) 0.78
The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis. Int J Clin Rheumtol (2012) 0.78
The potential for the noninvasive delivery of polymeric nanocarriers using propellant-based inhalers in the treatment of Chlamydial respiratory infections. Biomaterials (2010) 0.78
The pathogenic role of Chlamydia in spondyloarthritis. Curr Opin Rheumatol (2010) 0.78
PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections. Nanomedicine (2011) 0.78
Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae elementary bodies to host cells. Microb Pathog (2007) 0.77
Seasonal variation in detection of bacterial DNA in arthritic stifle joints of dogs with cranial cruciate ligament rupture using PCR amplification of the 16S rRNA gene. Vet Microbiol (2009) 0.76
Transmission of Chlamydophila pneumoniae from dendritic cells to macrophages does not require cell-to-cell contact in vitro. J Microbiol Methods (2007) 0.76
Ultrastructural Analysis of Chlamydia Pneumoniae in the Alzheimer's Brain. Pathogenesis (Amst) (1999) 0.76